Head of Goverment Affairs España y Portugal
Guarda esta oferta y sigue tu búsqueda
Crea una cuenta gratis para guardar empleos, crear alertas y volver a esta oferta desde tu panel.
Al continuar, aceptas nuestros Términos & Política de Privacidad.
This is where your work makes a difference. At Baxter, we believe every person—regardless of who they are or where they are from—deserves a chance to live a healthy life. It was our founding belief in 1931 and continues to be our guiding principle. We are redefining healthcare delivery to make a greater impact today, tomorrow, and beyond. Our Baxter colleagues are united by our Mission to Save and Sustain Lives. Together, our community is driven by a culture of courage, trust, and collaboration. Every individual is empowered to take ownership and make a meaningful impact. We strive for efficient and effective operations, and we hold each other accountable for delivering exceptional results. Here, you will find more than just a job—you will find purpose and pride.
¿Quiere enviar su solicitud? Lea toda la información sobre este puesto a continuación y luego pulse el botón de solicitar.
This multi-hatted senior leadership role combines direct Government Affairs and Market Access support across Spain & Portugal with Western Europe strategic portfolio leadership for Advanced Surgery, Compounding Services and Outpatient Parenteral Antimicrobial Therapy (OPAT). The role shapes healthcare policy, reimbursement, procurement, funding, tender and market access conditions across four distinct healthcare systems, while defining and driving the Western Europe Government Affairs and Market Access agenda for the assigned portfolios. The assigned business scope includes a $290 million 2025 EMEA Advanced Surgery revenue forecast, $533 million in 2026 Western Europe Drug Compounding net sales, and an approximately $40 million Western Europe OPAT business opportunity. The geographic basis differs by portfolio and is stated explicitly to avoid overstating a combined Western Europe figure. The position serves as a strategic advisor to Western Europe business and country leadership, influencing portfolio strategy, business planning, investment priorities, tender competitiveness, risk management and sustainable growth.
Distinctive Leadership Profile- Combines a priority-market leadership mandate in Spain with structured support for Portugal across all Baxter business segments.
- Provides Western Europe strategic leadership for three distinct business models: hospital-based surgical products, pharmacy and outsourced compounding services, and care-transition pathways for OPAT.
- Connects government affairs, reimbursement, evidence generation, tender strategy and service-model access to support both product and healthcare-service growth.
- Leads regional advocacy strategy and external-representation standards, providing a consistent policy voice across assigned markets and portfolios.
- Owns Government Affairs and Market Access strategy and outcomes for Spain, with defined support for Portugal.
- Sets multi-year policy, reimbursement, procurement, funding and stakeholder strategies across four distinct healthcare systems.
- Translates political, payer and healthcare-system developments into business priorities, investment choices and risk mitigation.
- Builds senior relationships with ministries, regional authorities, payers, procurement and assessment bodies, industry, professional and patient organizations.
- Shapes conditions affecting patient access, portfolio adoption, tender competitiveness, manufacturing investment and healthcare transformation.
- Leads compliant national and subnational advocacy and aligns Commercial, Medical, Regulatory, Finance, Supply Chain, Communications and Legal around integrated country plans.
- Defines and leads the Western Europe Government Affairs and Market Access strategy for Advanced Surgery, aligned with business priorities and country execution.
- Shapes tender, hospital-access, reimbursement and evidence strategies for a portfolio with a $290 million 2025 EMEA revenue forecast.
- Prioritizes assessment, real-world evidence and value propositions that differentiate surgical sealants, hemostats and adhesion-prevention solutions.
- Leads regional tender shaping, formulary access, value communication and stakeholder engagement, anticipating policy, funding and competitive risks.
- Scales evidence and best practices across markets, including economic-value support for Floseal differentiation.
- Defines and leads the Western Europe Government Affairs and Market Access agenda for Compounding Services, supporting $533 million in 2026 net sales.
- Shapes policy and access for hospital pharmacy, outsourced preparation, service contracting, reimbursement and third-party provision.
- Advises business leadership on market development, service-model expansion, profitability protection and ri